Ghorashian, S., Pulsipher, M., Silva, J., Rubio-San-Simon, A., Lipsitt, A., Bonney, D., Diaz-de-Heredia, C., Shenton, G., Shang, J., Saxena, K., Brugger, W., Lao-Sirieix, P., Maude, S. (2025). Treatment of pediatric patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) with obecabtagene autoleucel (obe-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy: Preliminary findings from the Phase Ib/II CATULUS trial. Blood. https://doi.org/10.1182/blood-2025-3337